<DOC>
	<DOCNO>NCT01061476</DOCNO>
	<brief_summary>Continuous positive airway pressure ( CPAP ) continue primary therapy prescribe treatment obstructive sleep apnea ( OSA ) . Although effective , adherence CPAP suboptimal many patient , make alternative therapy desirable . Recently , novel device ( Provent™ ) develop treatment snore OSA . The purpose current study examine well Provent™ device treat OSA particular attention may treat sleep apnea may likely benefit use treatment .</brief_summary>
	<brief_title>Sleep Apnea Treatment With Expiratory Resistance ( Provent™ )</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Consenting adult age 18 Diagnosed obstructive sleep apnea ( define RDI &gt; 5 event per hour &amp; ≥ 90 % disordered breathing event classify obstructive ) Total sleep time previous sleep study &lt; 4 hour ( 240 minute ) Severe bilateral nasal obstruction ( apparent mouth breathe rest ) Documented history lung disease , define : Daytime hypercapnia ( PaCO2 &gt; 45 mmHg ) Baseline SaO2 ≤ 92 % Chronic lung disease except mild intermittent mild persistent asthma Cor pulmonale Documented clinical cardiovascular disease , define : Myocardial infarction past 3 month Revascularization procedure past 3 month Implanted cardiac pacemaker ICD Unstable arrhythmias Congestive heart failure ejection fraction &lt; 40 % Uncontrolled hypertension ( BP &gt; 190/110 ) History end stage renal disease ( dialysis ) History end stage liver disease , : Jaundice Ascites History recurrent gastrointestinal bleeding Transjugular intrahepatic portosystemic shunt ( TIPS ) ; Sleep disorder obstructive sleep apnea , : Narcolepsy Restless leg syndrome Periodic limb movement cause arousal index &gt; 5 per hour Transportation industry worker ( commercial truck bus driver , airline pilot ) Known pregnancy ( self report ) Known coagulopathy anticoagulant use ( e.g . coumadin ) aspirin . Allergy lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>treatment</keyword>
	<keyword>collapsibility</keyword>
	<keyword>expiratory nasal resistance</keyword>
</DOC>